Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-20-030706

Options or other derivatives

  • Exec. Director, Finance - PAO acquired 5,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Jones Michael L Exec. Director, Finance - PAO 2020-12-03 Grant or award · Emp. Stock Option (Right to Buy) +5,000 5,000 D
Loading xslF345X03/form4.xml…